Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.
about
Fertility Risk Assessment and Preservation in Male and Female Prepubertal and Adolescent Cancer PatientsToward precision medicine for preserving fertility in cancer patients: existing and emerging fertility preservation options for womenImmunosuppressive drugs and fertilityUnique features of young age breast cancer and its managementPremature ovarian insufficiency: the context of long-term effectsReproductive issues in patients undergoing Hematopoietic Stem Cell Transplantation: an updateFertility preservation and GnRHa for chemotherapy: debate.Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.Folliculogenesis Is Not Fully Inhibited during GnRH Analogues Treatment in Mice Challenging Their Efficiency to Preserve the Ovarian Reserve during Chemotherapy in This Model.Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.Fertility status of Hodgkin lymphoma patients treated with chemotherapy and adjuvant gonadotropin-releasing hormone analoguesUnderstanding Fertility in Young Female Cancer Patients.Challenges and Potential for Ovarian Preservation with SERMs.Gonadotropin-Releasing Hormone Agonist Cotreatment During Chemotherapy May Increase Pregnancy Rate in SurvivorsFertility preservation and cancer: challenges for adolescent and young adult patients.Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.Female fertility preservation: a clinical perspective.The correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients.Current concepts in premature ovarian insufficiency.Preserving fertility when choosing chemotherapy regimens - the role of gonadotropin-releasing hormone agonists.An overview of pregnancy and fertility issues in breast cancer patients.Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin.Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.Pregnancy and Glomerular Disease: A Systematic Review of the Literature with Management Guidelines.Prevalence of premature ovarian failure in patients with systemic lupus erythematosus.Perspectives on the co-treatment with GnRHa in female patients undergoing hematopoietic stem cell transplantationCancer and fertility preservation: international recommendations from an expert meeting.Endocrine prevention of chemotherapy-induced ovarian failure.Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis.Fertility preservation in post-pubescent female cancer patients: A practical guideline for clinicians.Fertility preservation for medical reasons in girls and women: British fertility society policy and practice guideline.Controversies over the use of GnRH agonists for reduction of chemotherapy-induced gonadotoxicity.A gonadotropin-releasing hormone agonist for the prevention of docetaxel-induced gonadal damage.3-month triptorelin in premenopausal patients with hormone receptor-positive early breast cancer: a commentary and a retrospective experience.Fertility preservation for patients with breast cancer: The Korean Society for Fertility Preservation clinical guidelines.Perspectives from American Society of Clinical Oncology: translational and clinical research highlights in breast and colorectal cancers.Preservation of gonadal function in women undergoing chemotherapy: a systematic review and meta-analysis of the potential role for gonadotropin-releasing hormone agonists.Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives
P2860
Q26743355-E3AE6454-3D6D-412C-B089-CAC8ED06F922Q26771979-D95727AA-A073-47B1-989F-F78C8C523666Q26778587-DFCDAE45-8040-4CAF-BC38-379523D62A5DQ26821902-A60487C4-34B6-4312-AF41-CF602C8164B8Q28079341-4A9AC255-3311-4115-B94C-543D66B6A546Q28079998-F1B26BC1-265D-4A2A-B686-F5DBA91146ECQ34090263-F5BD7BED-EE62-4313-8B39-18D217A48C03Q35511100-B34936E0-EEAE-427E-879B-C3B78A770913Q35760872-FA08B497-31DB-48BF-B040-E554537191D1Q35766397-B9EECFDD-004D-49BF-9817-2FBD84C6C95BQ36010259-85087832-27A0-4C6B-9981-5182C381B445Q36218039-EE5841AF-91E1-412D-9377-226F252659A5Q36282795-A4550982-5F1D-499A-B1BC-4F8E9E6C0772Q36478738-8B792A62-FFC5-4268-8331-E491D980CED6Q36575987-6F7B4397-EE02-48E7-B50D-E120078D215CQ37213101-9A9473E6-FA06-40F3-B2BF-D07E6B0276BEQ37628888-49C78705-E207-4CF5-A528-40BD96815B47Q37706917-198CECFF-7CD3-4F97-BED1-D8DFF76D5C43Q38380077-265F704C-F616-41E1-A9C5-5ABCBC70DFE7Q38397291-51BC9B60-F88E-4956-AF94-A4F6CCD2E18CQ38626663-849A8E9E-89A6-46F4-960B-28A3E2525A74Q38913042-30108CF6-4DA9-4F1A-9894-3F981C6B2024Q39236911-DDE07BB1-FA93-44AC-8A91-C6044F62A6B6Q39316691-8ECB625A-9FD4-4453-8A5D-176D9FEF5AE3Q40200817-B6331E45-290E-4650-92FC-7E1BCDA8824CQ42635215-75733DAD-DE9F-40CE-B469-F4617B6DD7C1Q43106184-791509BE-2F51-4F68-942E-F97A486751FCQ43958170-81424219-B06B-40C3-8878-1B8791EEB407Q46144166-C6D97418-68DA-4D9D-B07F-A818C3ED9791Q47547600-49BF0F9E-1AAD-4F65-BE15-576BFE331D8FQ47558016-C0CADF68-B0A8-4793-9DF6-53A9ED2AD45DQ47656974-2FE530CB-F5F4-4F67-8CE0-C5402AD5CF46Q47764300-6CB6386B-7F17-4D03-BF32-48F116D3E069Q48329409-C4501DFA-7B46-4F82-B8C1-3956A43EA8CCQ48502529-006D8B80-8A90-4D57-8D8A-246D4CA751FDQ48716487-E9D21134-F374-486B-980E-217795C1DA3CQ53272116-DD9BF743-2B20-4755-A23B-36C38C9BEE91Q57093082-F153C8B9-FAF1-48D7-9AD5-9451530CE14D
P2860
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Gonadotropin-releasing hormone ...... analysis of randomized trials.
@ast
Gonadotropin-releasing hormone ...... analysis of randomized trials.
@en
Gonadotropin-releasing hormone ...... analysis of randomized trials.
@nl
type
label
Gonadotropin-releasing hormone ...... analysis of randomized trials.
@ast
Gonadotropin-releasing hormone ...... analysis of randomized trials.
@en
Gonadotropin-releasing hormone ...... analysis of randomized trials.
@nl
prefLabel
Gonadotropin-releasing hormone ...... analysis of randomized trials.
@ast
Gonadotropin-releasing hormone ...... analysis of randomized trials.
@en
Gonadotropin-releasing hormone ...... analysis of randomized trials.
@nl
P2093
P50
P1476
Gonadotropin-releasing hormone ...... analysis of randomized trials.
@en
P2093
Alessia D'Alonzo
Claudia Bighin
Francesca Poggio
Giuseppe Canavese
Sara Giraudi
P304
P356
10.1016/J.CTRV.2013.12.001
P50
P577
2013-12-08T00:00:00Z